← Back to Search

Virus Therapy

Treatment for Dry Mouth

N/A
Waitlist Available
Research Sponsored by MeiraGTx UK II Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights

Summary

This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia

Eligible Conditions
  • Dry Mouth

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
• Incidence of AEs, treatment-emergent adverse events (TEAEs), and SAEs
Secondary study objectives
Changes in saliva flow compared to baseline.
Changes in the MD Anderson Symptom Inventory - Head and Neck
Changes in the McMaster Global Rate of Change relative to Baseline
+1 more

Find a Location

Who is running the clinical trial?

MeiraGTx UK II LtdLead Sponsor
14 Previous Clinical Trials
686 Total Patients Enrolled
MeiraGTx, LLCLead Sponsor
5 Previous Clinical Trials
285 Total Patients Enrolled
~9 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top